Richardson, P. G., & Raab, M. (2014). Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma. Blood, 124(21), .
Chicago-Zitierstil (17. Ausg.)Richardson, Paul G., und Marc-Steffen Raab. "Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma." Blood 124, no. 21 (2014).
MLA-Zitierstil (9. Ausg.)Richardson, Paul G., und Marc-Steffen Raab. "Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma." Blood, vol. 124, no. 21, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.